Alternative medicine and hepatitis B

NEW YORK, July 31 (Praxis Press) Blood screening, immunization, and infection control policies have made hospital outbreaks of hepatitis B virus (HBV) infection rare; in contrast, community outbreaks of HBV remain problematic. Using molecular epidemiology, Webster and colleagues traced the origin and spread of HBV infection acquired by a woman who attended a London clinic for autohemotherapy. Sixteen percent of the 352 clinic patients 4 staff members tested had serologic evidence of HBV infectio


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NEW YORK, July 31 (Praxis Press) Blood screening, immunization, and infection control policies have made hospital outbreaks of hepatitis B virus (HBV) infection rare; in contrast, community outbreaks of HBV remain problematic. Using molecular epidemiology, Webster and colleagues traced the origin and spread of HBV infection acquired by a woman who attended a London clinic for autohemotherapy. Sixteen percent of the 352 clinic patients 4 staff members tested had serologic evidence of HBV infection. Ninety-one percent of 33 patients and staff members who were positive for hepatitis B surface antigen had matching nucleotide sequences for the surface and core genes. Analysis identified a patient as the likely source of the outbreak and contaminated saline as the probable vehicle. Despite heightened regulations and licensing requirements, patients attending alternative-medicine clinics are still at risk of bloodborne infections.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide